ArticleMolecular biology reports2026
Hepatic stellate cells promote structural and functional remodeling of three-dimensional hepatocellular carcinoma coculture spheroids.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatic stellate cells (HSCs) are major regulators of the hepatocellular carcinoma (HCC) tumor microenvironment, contributing to extracellular matrix remodeling, tumor progression, and therapeutic resistance. Although three-dimensional (3D) coculture spheroid models better represent tumor-stroma interactions than conventional monocultures, the impact of HSCs on spheroid architecture and function remains incompletely characterized. This study investigated how HSCs influence the structural and functional properties of a 3D HCC model. METHODS AND
resultsSpheroids were produced using HepG2 cells, LX-2 cells (HSCs), or a 1:1 coculture system (CCS) and characterized over 96 h. Morphometric analysis demonstrated that CCS spheroids exhibited reduced area and perimeter together with increased circularity and normalized solidity, indicating enhanced structural organization and compaction. Scanning electron microscopy (SEM) confirmed distinct ultrastructural organization among the spheroid models. Flow cytometry revealed fewer membrane-compromised cells in CCS spheroids than in HepG2 spheroids. Although the percentage of active caspase-3-positive cells was unchanged, active caspase-3 fluorescence intensity was lower in both HepG2-like and LX-2-like populations. CCS spheroids showed higher collagen type I alpha-1-associated fluorescence, predominantly in the α-SMA-positive compartment, consistent with a stromal collagen-producing phenotype. Biochemical analyses revealed distinct extracellular lactate profiles. Extracellular LDH activity was lower in CCS spheroids than in HepG2 spheroids, although normalized LDH release did not differ between these groups. Functionally, CCS spheroids displayed reduced sorafenib sensitivity, with an IC30 approximately 3-fold higher than HepG2 monoculture.
conclusionsLX-2 incorporation was associated with greater spheroid organization, increased collagen type I-related expression, altered cell-death and extracellular metabolic profiles, and reduced sorafenib sensitivity, supporting the value of HepG2/LX-2 coculture spheroids for studying selected tumor-stromal interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.